Quality and Outcome Measurements of Urological Patients
ConditionUrologic Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInsel Gruppe AG, University Hospital Bern
About this trial
Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients treated at the study sites, signed informed consent
Disqualifiers
No consent to record medical history
Trial population
Entire patient population that is treated at the study sites
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Standard of care
Other interventionPatients are treated according to the standard of care for each individual disease.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Disease specific primary endpoint
Neuronal networks will be trained to define the respective endpoints for the diseases
Time frame
4-5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Hospital Centre Biel/Bienne
Collaborator
Source ClinicalTrials.gov